Australia’s Therapeutic Goods Administration (TGA) has recently approved a new COVID booster. The shot was developed by ...

With Omicron still the prevailing strain of COVID-19 around the world, the new shot is now Moderna's "lead candidate for a fall 2022 booster," he added. Some expert groups, including the Joint ...

Moderna Inc. delivered better-than-expected profit and sales in the third quarter after an early start to sales of this season’s Covid boosters.

After last fall's rollout of that updated vaccine, JN.1 surfaced with more than 30 new mutations, which worried experts. Q: Can I mix and match the Pfizer and Moderna vaccines? A: It is not ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

(NEXSTAR) – Depending on when you last got vaccinated, that COVID-19 shot ... Moderna and Pfizer shots target the KP.2 variant, known as one of the FLiRT subtypes of omicron. The Novavax booster ...